IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Portfolio Profile

CIK: 0001643354 | NEW YORK, NY

Investment Profile

Style

Core

Turnover

Medium

Orientation

Concentrated trader
$20.9M
AUM
35
Positions
55.01%
Top 10 Conc.
90.1%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1CUE Biopharma Inc(CUE)52,928$1.7M7.99%
2Praxis Precision Medicines I(PRAX)4,450$1.5M7.13%
3Moonlake Immunotherapeutics(MLTX)67,500$1.3M6.29%
4Fennec Pharmaceuticals Inc(FENC)112,434$1.2M5.78%
5Royalty Pharma PLC(RPRX)21,400$1.2M5.74%
6

Sector Allocation

Latest filing, equity positions only

Healthcare89.71% · $18.8M
Unclassified10.29% · $2.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare91.57%89.71%-1.86%
Unclassified8.43%10.29%+1.86%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$224.4M | 31 pos.
$199.9M | 30 pos.
$179.0M | 32 pos.
$54.9M | 27 pos.
$44.9M | 25 pos.
$19.1M | 19 pos.
Compass Pathways PLC(CMPS)
80,000
$1.1M
5.41%
7Milestone Pharmaceuticals in(MIST)820,000$1.1M5.26%
8Benitec Biopharma Inc(BNTC)62,000$829.6K3.97%
9Syndax Pharmaceuticals Inc(SNDX)36,000$787.0K3.76%
10Biohaven LTD(BHVN)51,700$769.3K3.68%
Cap SizePrev %Curr %Change
Small Cap40.45%36.61%-3.84%
Mid Cap26.2%24.66%-1.54%
Micro Cap20.47%24.56%+4.09%
Unclassified8.43%10.29%+1.86%
Large Cap4.46%3.89%-0.57%
$15.7M | 21 pos.
$14.7M | 19 pos.
$17.6M | 27 pos.
$19.3M | 39 pos.
$16.7M | 35 pos.
$20.9M | 35 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

0
New
0
Closed
0
Increased
1
Decreased
34
Unchanged